NOS2 and Parkinson disease: 6-Shogaol also displayed a positive result in Parkinson disease by protecting dopaminergic neurons against MPTP−- and MPP+-induced neurotoxicity as well as inhibiting the release of nitric oxide and reduced the expression of inducible nitric oxide synthase (iNOS) [20, 21].